ClinicalTrials.Veeva

Menu

Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis

Montefiore Medicine Academic Health System logo

Montefiore Medicine Academic Health System

Status and phase

Withdrawn
Phase 4

Conditions

Liver Cirrhosis
Ascites Hepatic

Treatments

Biological: Albumin
Biological: Fresh Frozen Plasma (FFP)

Study type

Interventional

Funder types

Other

Identifiers

NCT03202524
2017-8009

Details and patient eligibility

About

Large volume paracentesis with albumin administration is the standard of care for patients with refractory ascites complicating end-stage liver disease. However, the use of albumin is frequently limited due to expense and occasional short supply. The goal of this study is to demonstrate if the administration of fresh frozen plasma (FFP) is as effective as albumin for volume expansion at the time of a large volume paracentesis.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 years or older
  2. Cirrhosis of the liver based on biopsy or clinical and radiographic criteria
  3. Ability to provide informed consent (Grade 0 to 1 HE)
  4. Grade 3 ascites or refractory ascites
  5. Ascites requiring frequent large volume paracentesis of at least 5 liters at least once a month
  6. No diuretic use

Exclusion criteria

  1. Inability to obtain informed consent
  2. Age less than 18
  3. Hepatic Encephalopathy Grade > 1
  4. Septic shock
  5. Active infection
  6. Respiratory failure
  7. Heart failure with reduced ejection fraction of ≤ 50%
  8. Moderate or severe pulmonary hypertension
  9. History of stroke
  10. Unstable coronary artery disease
  11. Chronic kidney disease (GFR <60)
  12. GI bleed within 2 weeks
  13. Any licorice within 2 weeks of starting the study
  14. Any Beta Blocker use within the last 2 weeks
  15. Any diuretic use within 2 weeks
  16. Absence of paracentesis within 2 weeks
  17. Absence of volume expanders within 2 weeks
  18. INR > 1.7

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Albumin
Active Comparator group
Description:
Patients undergoing large volume paracentesis with receive 50ml of 25% albumin for every 2 L removed from their abdomen.
Treatment:
Biological: Albumin
Fresh Frozen Plasma
Experimental group
Description:
Patients undergoing large volume paracentesis with receive 2 units of FFP for the first 4L removed followed by 50ml of 25% albumin for every additional 2 L removed
Treatment:
Biological: Fresh Frozen Plasma (FFP)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems